All News

Filter News

Filter by

News Type
Topic
Language
Published Date

Filter by News Type

Done

Filter by Topic

Done

Filter by Language

Done

Filter by Published Date

Done
Showing 10 out of 199 results
|
Research Feature
In 1993, the NHLBI’s Women's Health Initiative (WHI) began enrolling the first participants in what would become one of the most definitive, far-reaching clinical trials of post-menopausal women's health ever undertaken in the U.S. During its more than 20 years of work, this long-term national health study of 161,808 women aged 50-79 has focused on...
red blood cells
|
Research Feature
REDSIII Team Cropped.jpg
This is the last installment in a three-part series about the NHLBI AIDS Program. The first installment covered the program’s work within the cardiovascular space . The second installment discussed the intersection between HIV research and lung research . Tremendous progress in the treatment of...
|
Research Feature
Lung HIV Study Steering Committee Cropped.jpg
This is the second in a three-part series about the NHLBI AIDS Program. The first installment covered the program’s work within the cardiovascular space. The third installment looks at the potential for stem cells, and other treatment options, to cure HIV. Tremendous progress in the treatment...
red blood cells
|
Research Feature
Tremendous progress in the treatment of HIV has led to increased survival and a dramatic evolution of the disease’s course in patients. The clinical challenges confronting the population have now shifted from AIDS-related illnesses to chronic diseases, such as coronary artery disease, chronic obstructive lung disease, and chronic anemia. Multiple...
Baby sleeping with plush toy.
|
Research Feature
smiling baby.JPG
The National Heart, Lung, and Blood Institute (NHLBI)-supported Pediatric Cardiac Genomics Consortium recently released its first dataset into the NIH's database of Genotypes and Phenotypes (dbGaP) , enabling any researcher to analyze the genes of children with congenital heart diseases on a...
human heart anatomy
|
Research Feature
Is the randomized registry trial the next “disruptive technology” in clinical research? That is the question posed and discussed by Dr. Michael Lauer , director of the NHLBI’s Division of Cardiovascular Sciences, and co-author Dr. Ralph B. D’Agostino from Boston University and the Harvard Clinical Research Institute in their recent New England...
Toddler, held by an adult, being examined by a medical professional
|
Research Feature
iStock_000022543507XSmall.jpg
Each year, almost 1 percent of all newborns –about 35,000 babies—enter this world with a congenital heart defect. In some cases the defect is minor and causes no complications, but other times these defects can be serious or even life threatening. Given the powerful responses children in...
|
Research Feature
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has launched an $87.2 million international research program to extend a highly successful program assessing blood banking and transfusion medicine. Research conducted under the seven-year program will focus on improving transfusion benefits and reducing its...
Blood cells
|
Research Feature
The NHLBI and Sickle Cell Disease The NHLBI has researched sickle cell disease since its founding as the National Heart Institute in 1948. Since 1972, when the National Sickle Cell Anemia Control act was passed, the NHLBI has spent more than $1 billion researching the condition. The NHLBI funds basic research and large clinical trials and conducts...